Latest Breaking News On - கேன் மலோந் - Page 1 : comparemela.com
Commissioners agreed to not renew the state-of-emergency, which allows virtual-only meetings
sturgisjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sturgisjournal.com Daily Mail and Mail on Sunday newspapers.
Commissioners approved a request regarding an exception to the hiring freeze
sturgisjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sturgisjournal.com Daily Mail and Mail on Sunday newspapers.
L2C Partners, a consulting firm that offers outsourced technology transfer and commercialization services.
Keeley, a biomedical engineer and veteran technology commercialization expert, will lead Lankenau Ventures’ core objective to license inventions from LIMR that focus on the operating room, the hospital patient room and other healthcare venues. In commercializing those inventions, the qualities of safety, quality and efficacy will be matched with market demand to determine priorities for product development.
“We’ve worked with Dan on several projects over the years and are really impressed with his skill at commercializing products,” said Ken Malone, Executive Officer with Early Charm. “With Dan’s leadership, this important joint venture can begin its work of bringing to the market new technologies to improve the lives of patients.”
Lankenau Ventures: New Business Model Moves Health Workers Inventions to Market Acapreneurial(TM) Initiative Combines Commercialization, Research and Innovation
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
(0)
WYNNEWOOD, PA / ACCESSWIRE / May 19, 2021 / Lankenau Ventures is a new business established to accelerate development and commercialization of medical inventions conceived by frontline healthcare workers. It is an initiative comprising a leading medical research institute and commercialization and entrepreneurship experts.
The joint venture includes the Lankenau Institute for Medical Research (LIMR; the research division of Main Line Health) and L2C Partners, both in Philadelphia and Early Charm in Baltimore. Main Line Health s deep belief in the power of their frontline health workers to invent the future of healthcare motivated us to join their effort, said Ken Malone, Executive Officer of Early Charm. Their unique organizational vision, trademarked under the name acapreneurial